-

2022 Insights on NRT Smoking Cessation Aids in the United States - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "NRT Smoking Cessation Aids in the US" report has been added to ResearchAndMarkets.com's offering.

After years of reviewing Juul's application to remain on the market, in June 2022 the US Food and Drug Administration (FDA) ordered the company to immediately stop selling its e-cigarette.

While critics of the company immediately celebrated the FDA ban, the reactions of Juul users were mixed. Some immediately flocked to retailers trying to secure remaining inventory, others stated that this was a sign to quit cold turkey, and a handful of users turned to NRT smoking cessations.

The NRT Smoking Cessation Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the NRT Smoking Cessation Aids market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Key Topics Covered:

NRT SMOKING CESSATION AIDS IN THE US

KEY DATA FINDINGS

2022 DEVELOPMENTS

  • FDA temporarily places ban on Juul products, leaving its status in the US market unclear
  • COVID-19 fears are left behind for many, and so is the desire to quit smoking
  • Embracing digital innovation and subscription services could open avenues for growth

PROSPECTS AND OPPORTUNITIES

Long-term impact of banning vaping devices unclear in the US

  • Regulation set to define the future of smoking and NRT cessation aids
  • Leading brands likely to explore opportunities in nicotine-free alternatives

CATEGORY INDICATORS

CATEGORY DATA

CONSUMER HEALTH IN THE US

EXECUTIVE SUMMARY

  • Consumer health in 2022: The big picture
  • 2022 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
  • Summary 1 OTC: Switches 2021-2022

DISCLAIMER

DEFINITIONS

SOURCES

For more information about this report visit https://www.researchandmarkets.com/r/fwb0lx

Source: Euromonitor International

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Commercial Gas Rice Cookers Market Report 2026: Revenues Set to Reach $2 Billion by 2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Commercial Gas Rice Cookers Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Commercial Gas Rice Cookers Market is experiencing significant growth, evolving from USD 1.28 billion in 2025 to an anticipated USD 2.00 billion by 2032, driven by a CAGR of 6.52%. This market research report provides a comprehensive analysis of the commercial gas rice cooker sector, highlighting key drivers like foodservice efficiency, industria...

Artemisinin Combination Therapy Market to Grow by $194 Million During 2026-2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artemisinin Combination Therapy (ACT) market exemplifies dynamic growth and promising potential in the treatment of malaria. Expected to increase from USD 386.40 million in 2025 to USD 608.26 million by 2032, supported by a steady CAGR of 6.69%, this market highlights the evolving landscape for modern antimalarial solutions. At the core of AC...

Artificial Iris Market Growth Forecast (2026-2032) Featuring Strategic Profiles of Leading Players Art Eyes, BrightOcular, Ophtec, REPER-NN, Spectrum Surgical, VEO Ophthalmics and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artificial Iris Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artificial Iris Market has shown significant growth, expanding from USD 17.71 million in 2024 to USD 19.31 million in 2025 and is expected to reach USD 36.92 million by 2032, growing at a CAGR of 9.61%. As biomedical innovation, consumer trends, and regulatory evolution converge, new opportunities in artificial iris technologies are emerging. Artificial iris...
Back to Newsroom